Blueprint Medicines Corporation (BPMC) Debt/EBITDA US GAAP (year values) |
||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
Debt/EBITDA | 1.25 | -4.73 | 1.44 | 1.56 | -0.13 | 0.11 | ||
Changes by years, y/y, % | -38% | -478% | -130% | +8% | -109% |
Blueprint Medicines Corporation. Debt/EBITDA
Blueprint Medicines Corporation. Debt/EBITDA, changes, %
Blueprint Medicines Corporation (BPMC) Debt/EBITDA US GAAP (quarter values) |
||||||||
2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
Debt/EBITDA | 1.53 | 1.38 | 1.32 | -0.13 | 0.11 | 0.11 | ||
Changes by years, y/y, % | +105% | +27% | +3% | -108% | -92% | |||
Changes by quarters, q/q, % | -3% | -10% | -4% | -110% | -188% |